BioPharma Resources

Drug Trial Radar · NCT07358546

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

A Phase 1, Open-label, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Efimosfermin Alfa in Adults With Varying Degrees of Hepatic Impairment Due to Steatotic Liver Disease

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

32

Planned (sponsor's estimate)

Start

Mar 13, 2026

Primary completion

Oct 13, 2027

Study completion Oct 13, 2027

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Jan 22, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to study the pharmacokinetic (PK) and safety profiles of a single dose of efimosfermin alfa in participants with varying degrees of Hepatic Impairment (HI) (assessed by Child-Pugh score) due to steatotic liver disease, with and without significant alcohol consumption.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

  • Efimosfermin alfaDrug

    Efimosfermin alfa to be administrated subcutaneously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the serum drug concentration versus time curve from time zero to infinity (AUC[0-inf]) of efimosfermin alfaTime frame: Up to 90 Days
  2. Maximum observed serum drug concentration (Cmax) of efimosfermin alfaTime frame: Up to 90 Days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Rialto, California · Recruiting

  • GSK Investigational Site

    Miami Lakes, Florida · Recruiting

  • GSK Investigational Site

    Tampa, Florida · Recruiting

  • GSK Investigational Site

    Houston, Texas · Recruiting

  • GSK Investigational Site

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.